Expertise

He has more than 13 years of experience and expertise in

• Complex coronary intervention, including intra-coronary imaging and physiology assessments
• Structural heart interventions, including transcatheter aortic valve implantation (TAVI), aortic and mitral valvuloplasty, PFO/ASD closure, left atrial appendage closure, prosthetic perileak closure
• Renal artery denervation to treat resistant hypertension. He is Internationally recognised in this field, with numerous invited speaker opportunities.

He has also established a CT coronary angiography co-reporting service at Royal Prince Alfred Hospital and iMED (Newtown) and currently holds level A CT certification.

He was awarded his MBBS (Hons 1) from the University of Sydney in 2000; completed his advanced cardiology training at Royal Prince Alfred Hospital in 2006; and his PhD in 2009, supported by a NHF postgraduate research scholarship. He then undertook postdoctoral studies at Stanford University, whilst simultaneously training in interventional cardiology at Stanford University Medical Centre (2009-2010), supported by an NHMRC CJ Martin Overseas Fellowship Grant.

Research & Clinical Trials

As a cardiovascular researcher, he has published over 100 research papers and leads a program which aims to develop novel therapies to target atherosclerosis and its consequences, specifically targeting the inflammation that drives coronary plaque instability.

This program has attracted over $13 million in peer-reviewed research funding. He currently co-leads multiple NHMRC-funded international trials of colchicine in heart attack, stroke and long Covid-19 patients.